LASMIDITAN: New Acute migraine treatment

Lasmiditan is an oral medication for treatment of acute migraines. It is the first of its class of serotonin (5-HT)1F receptor agonists meaning that it acts on the chemical in our body called serotonin.

Two studies of lasmiditan found that patients had higher levels of pain relief compared to placebo after taking the medication and relief of migraine-associated symptoms 2 hours after taking it. There also may be particular benefit for patients who have nighttime migraines that interfere with sleep.

For more information about this medication call The Manhattan Center for Headache & Neurology. We look forward to meeting you!

Brooke Steiger, NP